Thi Mui Pham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thi Mui Pham has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Martin C. J. Bootsma
Julius Center for Health Sciences and Primary care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
7 shared publications - Mirjam Kretzschmar
Julius Center for Health Sciences and Primary care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
7 shared publications - Ganna Rozhnova
Julius Center for Health Sciences and Primary care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
4 shared publications Yue Zhang
4 shared publications- Alexandra Teslya
Julius Center for Health Sciences and Primary care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
3 shared publications Haojia Li
3 shared publications
Latest Publications
- Open Access
Trends in incidence and antimicrobial resistance for five major causes of bacteraemia in a Canadian metropolitan area, 2006–22: a genomic and antimicrobial use cohort study
Summary: Background: Using a population-based cohort from the Calgary Health Zone (CHZ), Canada, we integrated longitudinal antimicrobial susceptibility and prescribing data with the whole genome sequences of five major pathogens. We aimed to assess how antimicrobial resistance (AMR) responds to prescribing changes and determine which bacterial strains shape these dynamics. Methods: We analysed antibiotic prescribing rates, clinical and genomic data from 7,271 Staphylococcus aureus , 1,609 Enterococcus faecalis , 801 Enterococcus faecium , 11,363 Escherichia coli , and 2,319 Klebsiella pneumoniae isolates, associated with bacteraemia episodes in the CHZ between 2006–2022. Genomic clusters (referred to as strains) were identified using StrainGST and assigned to known sequence types (STs) or clonal complexes (CCs). Strain-level incidence, stratified by community-onset (isolates collected ≤48h after admission) and hospital-onset (>48h after admission), AMR phenotypes, and prescribing rates were modelled using negative-binomial and binomial regression. Temporal trends were quantified using average annual percentage change (AAPC). Findings: Between 2010–2022, fluoroquinolone prescribing declined in both community (AAPC=−6·8% [95% CI −8·1, −5·4]; pS aureus bacteraemia resistant to clinically important antibiotics, cloxacillin, ciprofloxacin, erythromycin, and clindamycin, declined from 2006 to 2022, mostly in hospital-onset cases (AAPC=−16·0%, [−19·3%, −12·7%], pE coli, ceftriaxone and ciprofloxacin resistance were clustered in ST131 and the emerging ST1193; the latter increased steadily, particularly in community-onset cases (AAPC=17·7%, [9·0%, 30·0%], pE coli ST131 strains increased (AAPC=23·8%, [17·4%, 30·5%], pE coli ST131 declined (AAPC=−15·9%, [−21·3%, −10·2%], pK pneumoniae , hypervirulent ST23 was most common (N=88) with an increasing trend in incidence (AAPC=2·3%, [−4·4%, 9·4%]) between 2006–2019. Conclusions: The contrasting resistance trends between Gram-positive and Gram-negative species underscore the complexity of AMR control efforts. Effective strategies will require stewardship efforts targeting multiple drug classes, genomic surveillance for emerging resistant strains, and interventions extending beyond hospital settings. Funding: This study was funded by a Large Scale Applied Research Project competition award (2017) from Genome Canada, administered via Genome Alberta. IAL is supported by an Alberta Innovates Translational Health Chair and a UCalgary Research Excellence Chair, with additional support from the Canada Foundation for Innovation (CFI-JELF 34986), the Natural Sciences and Engineering Research Council (DG 04547). Microbial isolates were prepared for analysis at the Alberta Centre for Advanced Diagnostics, which is supported by PrairiesCan (000022734). This work was also supported by federal funds from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under grant number U19AI110818 to the Broad Institute. JTS is additionally supported by the NIH/NIAID F32AI179151. Research in context: Evidence before this study: We searched PubMed for articles published in English up to Dec 23, 2025, using (antibiotic[tiab] OR antimicrobial[tiab]) AND (use[tiab] OR prescribing[tiab] OR consumption[tiab]) AND (resistance[tiab] OR “multidrug resistance“[tiab]) AND (relationship[tiab] OR association[tiab] OR correlation[tiab] OR effect[tiab] OR impact[tiab] OR influence[tiab] OR regression[tiab]) AND (genomic OR genetic OR “”molecular epidemiology) AND (“Staphylococcus aureus” OR “Escherichia coli” OR “Klebsiella pneumoniae” OR “Enterococcus faecalis” OR “Enterococcus faecium”) NOT animal. This search yielded 739 articles. Numerous studies have characterised the molecular epidemiology of these species over the past two decades: For Staphylococcus aureus , extensive genomic surveillance has revealed that a limited number of sequence types have dominated global infections over the past two to three decades. Pandemic hospital-associated methicillin resistant S aureus (MRSA) strains such as CC5, CC22, CC80, and CC30 were widely established in the 1990s and early 2000s, often carrying large multidrug-resistant staphylococcal cassette chromosome mec (SCCmec) elements. Since then, community-associated MRSA strains, including ST8 (CC8, USA300), ST59, and ST80, have emerged and expanded, frequently harbouring SCCmec IV or V. Livestock-associated MRSA ST398 has also become widespread, particularly in Europe and North America. While vancomycin resistance in S aureus remains rare, reduced susceptibility has been reported sporadically, especially in ST5 and ST8. Overall, the distribution of S aureus sequence types continues to shift regionally, with the spread of community-associated strains into hospitals. These patterns largely reflect data from high-income countries whereas strain distribution tends to be more heterogeneous in low-and middle-income countries. In Enterococcus faecium , genomic analyses have revealed a split population structure: clade A1 (clonal complex 17) comprises the vast majority of clinical, multidrug-resistant isolates, while clade B includes largely commensal, less drug-resistant strains circulating in the community. Globally, most clinical isolates now belong to clade A1 (CC17), which is characterised by near-universal ampicillin resistance, frequent vancomycin resistance, and additional resistance to aminoglycosides and fluoroquinolones. Since its emergence, CC17 E faecium has disseminated globally, with distinct subclones predominating in specific regions and time periods. In Europe and North America, ST17 and ST117 have become the predominant sequence types, commonly associated with vancomycin resistance and implicated in bloodstream infections. Although vancomycin resistance rates remain high in the USA and low in Canada, they have been relatively stable in recent years. Genomic epidemiology has shown that Enterococcus faecalis is more genetically diverse than E faecium , with a highly recombinogenic genome and no clear separation into distinct clades. Early vancomycin-resistant E faecalis reports in the 1990s were sporadic and genetically diverse, but by the 2000s and 2010s, expansions of hospital-associated strains such as ST6, ST87, and ST179 became more prominent, particularly in Europe and North America, frequently producing beta-lactamase and exhibiting resistance to vancomycin, and high-level gentamicin. For Klebsiella pneumoniae and Escherichia coli, studies have focused on the surveillance of extended-spectrum-beta-lactamase (ESBL) producing clones. The most common epidemic clones associated with multidrug resistance in E coli were ST131, ST1193, and ST69. The majority of ESBL-producing strains are attributed to CTX-M alleles with CTX-M-15 and CTX-M-14 being the predominant genotypes. Since 2000, the emergence of CTX-M-27, a single-nucleotide variant of CTX-M-14, has been increasingly reported. ESBL rates among hospital-associated E coli infections showed increasing trends in North America, Europe, and in many countries in Southeast and East Asia. ESBL rates varied considerably for K pneumoniae across different countries (15%–60%) with high rates primarily detected in Asia and in Southern and Eastern Europe. K pneumoniae bacteraemia was characterized by diverse strains with only a few associated with clonal outbreaks and hypervirulence, such as ST20, ST23, ST258, ST1. Only one study has comprehensively integrated clinical, genomic, and antibiotic prescribing data. Pöntinen and colleagues (2024) examined E coli bloodstream infections, showing that non-penicillin β-lactam use influenced the success of widespread multidrug-resistant, extended-spectrum beta-lactamase (ESBL)-producing E coli clones. However, no previous study has combined longitudinal clinical, genomic, and antibiotic use data across multiple major pathogens. Added value of this study: To our knowledge, this study is the first to integrate longitudinal clinical, genomic, and antibiotic prescribing data for five key bacterial pathogens for an entire region over almost two decades. This combined dataset provides a unique opportunity to analyse the impact of changing antibiotic use on antimicrobial resistance trends across multiple organisms, as well as explore how pathogen-specific strains adapt to these changes over time. Implications of all the available evidence: This study underscores the critical importance of integrated, pathogen-specific surveillance programs for guiding antimicrobial stewardship. The observed association between declining fluoroquinolone prescribing and reduced resistance among Gram-positive pathogens illustrates the potential impact of targeted prescribing interventions. At the same time, the heterogeneous responses across bacterial species to this change in practice highlight that stewardship strategies must be tailored, rather than one-size-fits-all. Continuous genomic surveillance is essential for anticipating resistance shifts and enabling timely detection and response to emerging threats, particularly from high-risk clones with the capacity for rapid dissemination. Finally, reducing antimicrobial resistance will require an integrated approach with hospital-based interventions along with coordinated efforts in the community to limit transmission and overall antibiotic exposure.
Open AccessTrends in incidence and antimicrobial resistance for five major causes of bacteraemia in a Canadian metropolitan area, 2006–22: a genomic and antimicrobial use cohort study
Summary: Background: Using a population-based cohort from the Calgary Health Zone (CHZ), Canada, we integrated longitudinal antimicrobial susceptibility and prescribing data with the whole genome sequences of five major pathogens. We aimed to assess how antimicrobial resistance (AMR) responds to prescribing changes and determine which bacterial strains shape these dynamics. Methods: We analysed antibiotic prescribing rates, clinical and genomic data from 7,271 Staphylococcus aureus , 1,609 Enterococcus faecalis , 801 Enterococcus faecium , 11,363 Escherichia coli , and 2,319 Klebsiella pneumoniae isolates, associated with bacteraemia episodes in the CHZ between 2006–2022. Genomic clusters (referred to as strains) were identified using StrainGST and assigned to known sequence types (STs) or clonal complexes (CCs). Strain-level incidence, stratified by community-onset (isolates collected ≤48h after admission) and hospital-onset (>48h after admission), AMR phenotypes, and prescribing rates were modelled using negative-binomial and binomial regression. Temporal trends were quantified using average annual percentage change (AAPC). Findings: Between 2010–2022, fluoroquinolone prescribing declined in both community (AAPC=−6·8% [95% CI −8·1, −5·4]; pS aureus bacteraemia resistant to clinically important antibiotics, cloxacillin, ciprofloxacin, erythromycin, and clindamycin, declined from 2006 to 2022, mostly in hospital-onset cases (AAPC=−16·0%, [−19·3%, −12·7%], pE coli, ceftriaxone and ciprofloxacin resistance were clustered in ST131 and the emerging ST1193; the latter increased steadily, particularly in community-onset cases (AAPC=17·7%, [9·0%, 30·0%], pE coli ST131 strains increased (AAPC=23·8%, [17·4%, 30·5%], pE coli ST131 declined (AAPC=−15·9%, [−21·3%, −10·2%], pK pneumoniae , hypervirulent ST23 was most common (N=88) with an increasing trend in incidence (AAPC=2·3%, [−4·4%, 9·4%]) between 2006–2019. Conclusions: The contrasting resistance trends between Gram-positive and Gram-negative species underscore the complexity of AMR control efforts. Effective strategies will require stewardship efforts targeting multiple drug classes, genomic surveillance for emerging resistant strains, and interventions extending beyond hospital settings. Funding: This study was funded by a Large Scale Applied Research Project competition award (2017) from Genome Canada, administered via Genome Alberta. IAL is supported by an Alberta Innovates Translational Health Chair and a UCalgary Research Excellence Chair, with additional support from the Canada Foundation for Innovation (CFI-JELF 34986), the Natural Sciences and Engineering Research Council (DG 04547). Microbial isolates were prepared for analysis at the Alberta Centre for Advanced Diagnostics, which is supported by PrairiesCan (000022734). This work was also supported by federal funds from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under grant number U19AI110818 to the Broad Institute. JTS is additionally supported by the NIH/NIAID F32AI179151. Research in context: Evidence before this study: We searched PubMed for articles published in English up to Dec 23, 2025, using (antibiotic[tiab] OR antimicrobial[tiab]) AND (use[tiab] OR prescribing[tiab] OR consumption[tiab]) AND (resistance[tiab] OR “multidrug resistance“[tiab]) AND (relationship[tiab] OR association[tiab] OR correlation[tiab] OR effect[tiab] OR impact[tiab] OR influence[tiab] OR regression[tiab]) AND (genomic OR genetic OR “”molecular epidemiology) AND (“Staphylococcus aureus” OR “Escherichia coli” OR “Klebsiella pneumoniae” OR “Enterococcus faecalis” OR “Enterococcus faecium”) NOT animal. This search yielded 739 articles. Numerous studies have characterised the molecular epidemiology of these species over the past two decades: For Staphylococcus aureus , extensive genomic surveillance has revealed that a limited number of sequence types have dominated global infections over the past two to three decades. Pandemic hospital-associated methicillin resistant S aureus (MRSA) strains such as CC5, CC22, CC80, and CC30 were widely established in the 1990s and early 2000s, often carrying large multidrug-resistant staphylococcal cassette chromosome mec (SCCmec) elements. Since then, community-associated MRSA strains, including ST8 (CC8, USA300), ST59, and ST80, have emerged and expanded, frequently harbouring SCCmec IV or V. Livestock-associated MRSA ST398 has also become widespread, particularly in Europe and North America. While vancomycin resistance in S aureus remains rare, reduced susceptibility has been reported sporadically, especially in ST5 and ST8. Overall, the distribution of S aureus sequence types continues to shift regionally, with the spread of community-associated strains into hospitals. These patterns largely reflect data from high-income countries whereas strain distribution tends to be more heterogeneous in low-and middle-income countries. In Enterococcus faecium , genomic analyses have revealed a split population structure: clade A1 (clonal complex 17) comprises the vast majority of clinical, multidrug-resistant isolates, while clade B includes largely commensal, less drug-resistant strains circulating in the community. Globally, most clinical isolates now belong to clade A1 (CC17), which is characterised by near-universal ampicillin resistance, frequent vancomycin resistance, and additional resistance to aminoglycosides and fluoroquinolones. Since its emergence, CC17 E faecium has disseminated globally, with distinct subclones predominating in specific regions and time periods. In Europe and North America, ST17 and ST117 have become the predominant sequence types, commonly associated with vancomycin resistance and implicated in bloodstream infections. Although vancomycin resistance rates remain high in the USA and low in Canada, they have been relatively stable in recent years. Genomic epidemiology has shown that Enterococcus faecalis is more genetically diverse than E faecium , with a highly recombinogenic genome and no clear separation into distinct clades. Early vancomycin-resistant E faecalis reports in the 1990s were sporadic and genetically diverse, but by the 2000s and 2010s, expansions of hospital-associated strains such as ST6, ST87, and ST179 became more prominent, particularly in Europe and North America, frequently producing beta-lactamase and exhibiting resistance to vancomycin, and high-level gentamicin. For Klebsiella pneumoniae and Escherichia coli, studies have focused on the surveillance of extended-spectrum-beta-lactamase (ESBL) producing clones. The most common epidemic clones associated with multidrug resistance in E coli were ST131, ST1193, and ST69. The majority of ESBL-producing strains are attributed to CTX-M alleles with CTX-M-15 and CTX-M-14 being the predominant genotypes. Since 2000, the emergence of CTX-M-27, a single-nucleotide variant of CTX-M-14, has been increasingly reported. ESBL rates among hospital-associated E coli infections showed increasing trends in North America, Europe, and in many countries in Southeast and East Asia. ESBL rates varied considerably for K pneumoniae across different countries (15%–60%) with high rates primarily detected in Asia and in Southern and Eastern Europe. K pneumoniae bacteraemia was characterized by diverse strains with only a few associated with clonal outbreaks and hypervirulence, such as ST20, ST23, ST258, ST1. Only one study has comprehensively integrated clinical, genomic, and antibiotic prescribing data. Pöntinen and colleagues (2024) examined E coli bloodstream infections, showing that non-penicillin β-lactam use influenced the success of widespread multidrug-resistant, extended-spectrum beta-lactamase (ESBL)-producing E coli clones. However, no previous study has combined longitudinal clinical, genomic, and antibiotic use data across multiple major pathogens. Added value of this study: To our knowledge, this study is the first to integrate longitudinal clinical, genomic, and antibiotic prescribing data for five key bacterial pathogens for an entire region over almost two decades. This combined dataset provides a unique opportunity to analyse the impact of changing antibiotic use on antimicrobial resistance trends across multiple organisms, as well as explore how pathogen-specific strains adapt to these changes over time. Implications of all the available evidence: This study underscores the critical importance of integrated, pathogen-specific surveillance programs for guiding antimicrobial stewardship. The observed association between declining fluoroquinolone prescribing and reduced resistance among Gram-positive pathogens illustrates the potential impact of targeted prescribing interventions. At the same time, the heterogeneous responses across bacterial species to this change in practice highlight that stewardship strategies must be tailored, rather than one-size-fits-all. Continuous genomic surveillance is essential for anticipating resistance shifts and enabling timely detection and response to emerging threats, particularly from high-risk clones with the capacity for rapid dissemination. Finally, reducing antimicrobial resistance will require an integrated approach with hospital-based interventions along with coordinated efforts in the community to limit transmission and overall antibiotic exposure.
- Open Access
- 31 July 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (9)
Antimicrobial selection and multidrug resistance in four major pathogens in the US Veterans Affairs health-care system: a multicentre, retrospective, cohort study
- 31 July 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (9)
Open AccessAntimicrobial selection and multidrug resistance in four major pathogens in the US Veterans Affairs health-care system: a multicentre, retrospective, cohort study
- Open Access
Impact of wildfire-related fine particulate matter on tuberculosis notifications in Brazil: a nationwide panel study, 2003–2023
Background: Wildfire activity and smoke exposure are increasing worldwide because of climate and land-use change. Although fine particulate matter (PM 2.5 ) may impair pulmonary immune defences against tuberculosis (TB), population-level evidence remains limited. We estimated the effect of wildfire-related PM 2.5 exposure on TB notification rates in Brazil. Methods: We conducted a nationwide panel study linking municipality-level monthly TB notifications from Brazil’s SINAN system with wildfire-related PM 2.5 estimates from GEOS-Chem simulations across 5,545 municipalities (2003-2023). We estimated the impact of high-exposure days (PM 2.5 >25µg/m³) on monthly TB notifications using Poisson regression with fixed effects for municipalities, state-by-year, and state-by-month, controlling for time-invariant differences, secular trends, and seasonality. Distributed lag effects were estimated over 1-24 months before notification. Models accounted for meteorological conditions, GeneXpert diagnostic coverage, and spatial correlation using Conley standard errors. We computed attributable fractions among exposed municipality-months (AFE). Sensitivity analyses evaluated alternative PM 2.5 thresholds (15, 35µg/m³), co-pollutants, and agricultural expansion. Findings: From Jan 1, 2003 to Dec 1, 2023, 1,758,982 TB cases were reported. Of these, 353,319 (20.1%) had at least one high-exposure day (PM 2.5 >25µg/m³) 1-24 months before notification. An additional 14 high-exposure days over the 24-month lag period was associated with an average monthly increase of 2.9% [95% CI: 0.9-4.9%] in TB notification rates. Effects peaked at 13 months (IQR: 11-14) prior to notification. Results showed a dose–response relationship across PM 2.5 thresholds and were robust to controlling for NO2, O3 and agricultural expansion. Overall, wildfire-related PM 2.5 exposure accounted for 2.1% [0.7-3.5%] of TB notifications in exposed municipality-months, corresponding to 7,802 [2,612-12,544] attributable cases. The AFE reached 10.7% [7.1-14.0%] in Pantanal and 7.3% [6.1-8.5%] in Amazônia, areas most impacted by wildfires. Interpretation: Wildfire-related PM 2.5 exposure may represent an increasingly important and modifiable risk factor for TB. As wildfire activity increases across many regions of the world, these findings highlight the need for integrating air quality into climate adaptation and TB control strategies. Funding: National Institutes of Health K01AI173385; University of Utah 3i Initiative
Open AccessImpact of wildfire-related fine particulate matter on tuberculosis notifications in Brazil: a nationwide panel study, 2003–2023
Background: Wildfire activity and smoke exposure are increasing worldwide because of climate and land-use change. Although fine particulate matter (PM 2.5 ) may impair pulmonary immune defences against tuberculosis (TB), population-level evidence remains limited. We estimated the effect of wildfire-related PM 2.5 exposure on TB notification rates in Brazil. Methods: We conducted a nationwide panel study linking municipality-level monthly TB notifications from Brazil’s SINAN system with wildfire-related PM 2.5 estimates from GEOS-Chem simulations across 5,545 municipalities (2003-2023). We estimated the impact of high-exposure days (PM 2.5 >25µg/m³) on monthly TB notifications using Poisson regression with fixed effects for municipalities, state-by-year, and state-by-month, controlling for time-invariant differences, secular trends, and seasonality. Distributed lag effects were estimated over 1-24 months before notification. Models accounted for meteorological conditions, GeneXpert diagnostic coverage, and spatial correlation using Conley standard errors. We computed attributable fractions among exposed municipality-months (AFE). Sensitivity analyses evaluated alternative PM 2.5 thresholds (15, 35µg/m³), co-pollutants, and agricultural expansion. Findings: From Jan 1, 2003 to Dec 1, 2023, 1,758,982 TB cases were reported. Of these, 353,319 (20.1%) had at least one high-exposure day (PM 2.5 >25µg/m³) 1-24 months before notification. An additional 14 high-exposure days over the 24-month lag period was associated with an average monthly increase of 2.9% [95% CI: 0.9-4.9%] in TB notification rates. Effects peaked at 13 months (IQR: 11-14) prior to notification. Results showed a dose–response relationship across PM 2.5 thresholds and were robust to controlling for NO2, O3 and agricultural expansion. Overall, wildfire-related PM 2.5 exposure accounted for 2.1% [0.7-3.5%] of TB notifications in exposed municipality-months, corresponding to 7,802 [2,612-12,544] attributable cases. The AFE reached 10.7% [7.1-14.0%] in Pantanal and 7.3% [6.1-8.5%] in Amazônia, areas most impacted by wildfires. Interpretation: Wildfire-related PM 2.5 exposure may represent an increasingly important and modifiable risk factor for TB. As wildfire activity increases across many regions of the world, these findings highlight the need for integrating air quality into climate adaptation and TB control strategies. Funding: National Institutes of Health K01AI173385; University of Utah 3i Initiative
- Open Access
Antimicrobial selection for resistance in four major pathogens in the US Veterans Affairs Healthcare System, 2007-2021
Background: Systematic evidence on antimicrobial selection for antimicrobial resistance (AMR) is scarce. We estimated the effect of prescribing key antibiotic classes on AMR across U.S. Veterans Affairs Medical Centres (VAMC). Methods: We analysed clinical isolates of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae , and Pseudomonas aeruginosa from 138 VAMC from Feb 1, 2007 to Dec 31, 2021. Antimicrobial prescribing was measured as inpatient days of therapy per 1000 patient-days; multidrug resistance as number of resistant phenotypes per 1,000 admissions. Temporal trends were modelled using generalized estimating equations and average annual percentage changes (AAPC). Multilevel multinomial logistic regression related facility-level antibiotic prescribing (days of therapy per 100 patient-days in the last 14d) to the relative odds of resistant phenotypes. Findings: Hospital-onset infection incidence declined for all pathogens, except third-generation cephalosporin (3GC)-resistant E coli . Antimicrobial prescribing remained stable or decreased, except 3GC prescribing, which increased from 2007 until 2019 (AAPC=2·4%, 95% CI 1·3%–3·5%, p-valueS aureus , each day of FQL treatment was linked to a 4·6% (95CI: 1·5, 7·7, p-value=0.0127) increase in the relative odds of isolating FQL-resistant, macrolide-susceptible, methicillin-resistant S aureus . Anti-staphylococcal beta-lactams were not linked to MRSA. Each day of 3GC treatment increased the odds of isolating 3GC- and beta-lactam/beta-lactamase-resistant E coli by 5·2% (95%CI: 1·3%, 9·4%, p-value=0.0079) and K pneumoniae by 3·0% (95% CI: −0·1%-6·2%, p-value=0.0600). Each day of carbapenem treatment increased the odds of carbapenem-resistant, FQL- and BL/BLI-susceptible P aeruginosa by 15·7% (95%CI: 9·4%, 22·4%, p-valueE coli . These findings underscore the need for comprehensive stewardship that coordinates strategies across antimicrobials.
Open AccessAntimicrobial selection for resistance in four major pathogens in the US Veterans Affairs Healthcare System, 2007-2021
Background: Systematic evidence on antimicrobial selection for antimicrobial resistance (AMR) is scarce. We estimated the effect of prescribing key antibiotic classes on AMR across U.S. Veterans Affairs Medical Centres (VAMC). Methods: We analysed clinical isolates of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae , and Pseudomonas aeruginosa from 138 VAMC from Feb 1, 2007 to Dec 31, 2021. Antimicrobial prescribing was measured as inpatient days of therapy per 1000 patient-days; multidrug resistance as number of resistant phenotypes per 1,000 admissions. Temporal trends were modelled using generalized estimating equations and average annual percentage changes (AAPC). Multilevel multinomial logistic regression related facility-level antibiotic prescribing (days of therapy per 100 patient-days in the last 14d) to the relative odds of resistant phenotypes. Findings: Hospital-onset infection incidence declined for all pathogens, except third-generation cephalosporin (3GC)-resistant E coli . Antimicrobial prescribing remained stable or decreased, except 3GC prescribing, which increased from 2007 until 2019 (AAPC=2·4%, 95% CI 1·3%–3·5%, p-valueS aureus , each day of FQL treatment was linked to a 4·6% (95CI: 1·5, 7·7, p-value=0.0127) increase in the relative odds of isolating FQL-resistant, macrolide-susceptible, methicillin-resistant S aureus . Anti-staphylococcal beta-lactams were not linked to MRSA. Each day of 3GC treatment increased the odds of isolating 3GC- and beta-lactam/beta-lactamase-resistant E coli by 5·2% (95%CI: 1·3%, 9·4%, p-value=0.0079) and K pneumoniae by 3·0% (95% CI: −0·1%-6·2%, p-value=0.0600). Each day of carbapenem treatment increased the odds of carbapenem-resistant, FQL- and BL/BLI-susceptible P aeruginosa by 15·7% (95%CI: 9·4%, 22·4%, p-valueE coli . These findings underscore the need for comprehensive stewardship that coordinates strategies across antimicrobials.
- 13 August 2024
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 24 (12) , 1333-1346
Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)
- 13 August 2024
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 24 (12) , 1333-1346
Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)
- Open Access
- 18 October 2023
- Published by Springer Nature in Nature
- Vol. 623 (7985) , 132-138
The burden and dynamics of hospital-acquired SARS-CoV-2 in England
Hospital-based transmission had a dominant role in Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV) epidemics1,2, but large-scale studies of its role in the SARS-CoV-2 pandemic are lacking. Such transmission risks spreading the virus to the most vulnerable individuals and can have wider-scale impacts through hospital–community interactions. Using data from acute hospitals in England, we quantify within-hospital transmission, evaluate likely pathways of spread and factors associated with heightened transmission risk, and explore the wider dynamical consequences. We estimate that between June 2020 and March 2021 between 95,000 and 167,000 inpatients acquired SARS-CoV-2 in hospitals (1% to 2% of all hospital admissions in this period). Analysis of time series data provided evidence that patients who themselves acquired SARS-CoV-2 infection in hospital were the main sources of transmission to other patients. Increased transmission to inpatients was associated with hospitals having fewer single rooms and lower heated volume per bed. Moreover, we show that reducing hospital transmission could substantially enhance the efficiency of punctuated lockdown measures in suppressing community transmission. These findings reveal the previously unrecognized scale of hospital transmission, have direct implications for targeting of hospital control measures and highlight the need to design hospitals better equipped to limit the transmission of future high-consequence pathogens.
- 18 October 2023
- Published by Springer Nature in Nature
- Vol. 623 (7985) , 132-138
Open AccessThe burden and dynamics of hospital-acquired SARS-CoV-2 in England
Hospital-based transmission had a dominant role in Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV) epidemics1,2, but large-scale studies of its role in the SARS-CoV-2 pandemic are lacking. Such transmission risks spreading the virus to the most vulnerable individuals and can have wider-scale impacts through hospital–community interactions. Using data from acute hospitals in England, we quantify within-hospital transmission, evaluate likely pathways of spread and factors associated with heightened transmission risk, and explore the wider dynamical consequences. We estimate that between June 2020 and March 2021 between 95,000 and 167,000 inpatients acquired SARS-CoV-2 in hospitals (1% to 2% of all hospital admissions in this period). Analysis of time series data provided evidence that patients who themselves acquired SARS-CoV-2 infection in hospital were the main sources of transmission to other patients. Increased transmission to inpatients was associated with hospitals having fewer single rooms and lower heated volume per bed. Moreover, we show that reducing hospital transmission could substantially enhance the efficiency of punctuated lockdown measures in suppressing community transmission. These findings reveal the previously unrecognized scale of hospital transmission, have direct implications for targeting of hospital control measures and highlight the need to design hospitals better equipped to limit the transmission of future high-consequence pathogens.
- Open Access
- 11 May 2022
- Published by The Royal Society in Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences
- Vol. 478 (2261) , 20210746
The potential impact of intensified community hand hygiene interventions on respiratory tract infections: a modelling study
Hand hygiene is among the most fundamental and widely used behavioural measures to reduce the person-to-person spread of human pathogens and its effectiveness as a community intervention is supported by evidence from randomized trials. However, a theoretical understanding of the relationship between hand hygiene frequency and change in risk of infection is lacking. Using a simple model-based framework for understanding the determinants of hand hygiene effectiveness in preventing viral respiratory tract infections, we show that a crucial, but overlooked, determinant of the relationship between hand hygiene frequency and risk of infection via indirect transmission is persistence of viable virus on hands. If persistence is short, as has been reported for influenza, hand-washing needs to be performed very frequently or immediately after hand contamination to substantially reduce the probability of infection. When viable virus survival is longer (e.g. in the presence of mucus or for some enveloped viruses) less frequent hand washing can substantially reduce the infection probability. Immediate hand washing after contamination is consistently more effective than at fixed-time intervals. Our study highlights that recommendations on hand hygiene should be tailored to persistence of viable virus on hands and that more detailed empirical investigations are needed to help optimize this key intervention.
- 11 May 2022
- Published by The Royal Society in Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences
- Vol. 478 (2261) , 20210746
Open AccessThe potential impact of intensified community hand hygiene interventions on respiratory tract infections: a modelling study
Hand hygiene is among the most fundamental and widely used behavioural measures to reduce the person-to-person spread of human pathogens and its effectiveness as a community intervention is supported by evidence from randomized trials. However, a theoretical understanding of the relationship between hand hygiene frequency and change in risk of infection is lacking. Using a simple model-based framework for understanding the determinants of hand hygiene effectiveness in preventing viral respiratory tract infections, we show that a crucial, but overlooked, determinant of the relationship between hand hygiene frequency and risk of infection via indirect transmission is persistence of viable virus on hands. If persistence is short, as has been reported for influenza, hand-washing needs to be performed very frequently or immediately after hand contamination to substantially reduce the probability of infection. When viable virus survival is longer (e.g. in the presence of mucus or for some enveloped viruses) less frequent hand washing can substantially reduce the infection probability. Immediate hand washing after contamination is consistently more effective than at fixed-time intervals. Our study highlights that recommendations on hand hygiene should be tailored to persistence of viable virus on hands and that more detailed empirical investigations are needed to help optimize this key intervention.
- Open Access
Seasonal patterns of SARS-CoV-2 transmission in secondary schools: a modelling study
Background The Omicron variant has caused a new wave of SARS-CoV-2 infections worldwide. We explore crucial epidemiological parameters driving seasonal patterns of SARS-CoV-2 transmission in secondary schools and assess various infection control interventions over a 2.5-year time frame. Methods We developed an agent-based model parameterised with data from secondary schools in the Netherlands. We modelled the circulation of Omicron assuming a stable introduction rate of infections and accounted for uncertainty in epidemiological parameters describing virus transmissibility, susceptibility to reinfection, vaccine immune escape, and waning of sterilising immunity. We quantified the SARS-CoV-2 health burden defined as number of symptomatic student days. We further evaluated the cost-benefit (number of prevented infected students per absent student) for reactive quarantine interventions, regular screening using antigen tests, and annual booster vaccinations. Findings Durability of sterilising immunity is a key parameter that governs temporal SARS-CoV-2 transmission patterns in secondary schools. Our model predicts pronounced within-school seasonal patterns with dominant autumn outbreaks and smaller winter outbreaks and a maximum prevalence of 2.9% (95% CI: 0.7%-6.6%) symptomatic students during infection peaks. Regular screening and annual booster vaccination may reduce the health burden up to 15% (95% CI: 1.5%-27.8%) and have a higher cost-benefit ratio than reactive quarantine interventions (reduction: 4.3%; 95% CI: -10.1% to 17.6%). Interpretation Immunity waning will determine the intensity and pattern of SARS-CoV-2 transmission in secondary schools in the medium-term future. If mitigation strategies are needed, screening and annual booster vaccination have the highest cost-benefit by reducing viral transmission with little educational disruption.
Open AccessSeasonal patterns of SARS-CoV-2 transmission in secondary schools: a modelling study
Background The Omicron variant has caused a new wave of SARS-CoV-2 infections worldwide. We explore crucial epidemiological parameters driving seasonal patterns of SARS-CoV-2 transmission in secondary schools and assess various infection control interventions over a 2.5-year time frame. Methods We developed an agent-based model parameterised with data from secondary schools in the Netherlands. We modelled the circulation of Omicron assuming a stable introduction rate of infections and accounted for uncertainty in epidemiological parameters describing virus transmissibility, susceptibility to reinfection, vaccine immune escape, and waning of sterilising immunity. We quantified the SARS-CoV-2 health burden defined as number of symptomatic student days. We further evaluated the cost-benefit (number of prevented infected students per absent student) for reactive quarantine interventions, regular screening using antigen tests, and annual booster vaccinations. Findings Durability of sterilising immunity is a key parameter that governs temporal SARS-CoV-2 transmission patterns in secondary schools. Our model predicts pronounced within-school seasonal patterns with dominant autumn outbreaks and smaller winter outbreaks and a maximum prevalence of 2.9% (95% CI: 0.7%-6.6%) symptomatic students during infection peaks. Regular screening and annual booster vaccination may reduce the health burden up to 15% (95% CI: 1.5%-27.8%) and have a higher cost-benefit ratio than reactive quarantine interventions (reduction: 4.3%; 95% CI: -10.1% to 17.6%). Interpretation Immunity waning will determine the intensity and pattern of SARS-CoV-2 transmission in secondary schools in the medium-term future. If mitigation strategies are needed, screening and annual booster vaccination have the highest cost-benefit by reducing viral transmission with little educational disruption.
- Open Access
- 21 March 2022
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 150, e79
The effect of hand hygiene frequency on reducing acute respiratory infections in the community: a meta-analysis
Hand hygiene is a simple, low-cost intervention that may lead to substantial population-level effects in suppressing acute respiratory infection epidemics. However, quantification of the efficacy of hand hygiene on respiratory infection in the community is lacking. We searched PubMed for randomised controlled trials on the effect of hand hygiene for reducing acute respiratory infections in the community published before 11 March 2021. We performed a meta-regression analysis using a Bayesian mixed-effects model. A total of 105 publications were identified, out of which six studies reported hand hygiene frequencies. Four studies were performed in household settings and two were in schools. The average number of handwashing events per day ranged from one to eight in the control arms, and four to 17 in the intervention arms. We estimated that a single hand hygiene event is associated with a 3% (80% credible interval (−1% to 7%)) decrease in the daily probability of an acute respiratory infection. Three of these six studies were potentially at high risk of bias because the primary outcome depended on self-reporting of upper respiratory tract symptoms. Well-designed trials with an emphasis on monitoring hand hygiene adherence are needed to confirm these findings.
- 21 March 2022
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 150, e79
Open AccessThe effect of hand hygiene frequency on reducing acute respiratory infections in the community: a meta-analysis
Hand hygiene is a simple, low-cost intervention that may lead to substantial population-level effects in suppressing acute respiratory infection epidemics. However, quantification of the efficacy of hand hygiene on respiratory infection in the community is lacking. We searched PubMed for randomised controlled trials on the effect of hand hygiene for reducing acute respiratory infections in the community published before 11 March 2021. We performed a meta-regression analysis using a Bayesian mixed-effects model. A total of 105 publications were identified, out of which six studies reported hand hygiene frequencies. Four studies were performed in household settings and two were in schools. The average number of handwashing events per day ranged from one to eight in the control arms, and four to 17 in the intervention arms. We estimated that a single hand hygiene event is associated with a 3% (80% credible interval (−1% to 7%)) decrease in the daily probability of an acute respiratory infection. Three of these six studies were potentially at high risk of bias because the primary outcome depended on self-reporting of upper respiratory tract symptoms. Well-designed trials with an emphasis on monitoring hand hygiene adherence are needed to confirm these findings.
- Open Access
The importance of sustained compliance with physical distancing during COVID-19 vaccination rollout
Mass vaccination campaigns against SARS-CoV-2 are ongoing in many countries with increasing vaccination coverage enabling relaxation of lockdowns. Vaccination rollout is frequently supplemented with advisory from public health authorities for continuation of physical distancing measures. Compliance with these measures is waning while more transmissible virus variants such as Alpha (B.1.1.7) and Delta (B.1.617.2) have emerged. In this work, we considered a population where the waning of compliance depends on vaccine coverage. We used a SARS-CoV-2 transmission model which captures the feedback between compliance, infection incidence, and vaccination coverage to investigate factors that contribute to the increase of the prevalence of infection during the initial stages of the vaccination rollout as compared to no vaccination scenario. We analysed how the vaccine uptake rate affects cumulative numbers of new infections three and six months after the start of vaccination. Our results suggest that the combination of fast waning compliance in non-vaccinated population, low compliance in vaccinated population and more transmissible virus variants may result in a higher cumulative number of new infections than in a situation without vaccination. These adverse effects can be alleviated if vaccinated individuals do not revert to pre-pandemic contact rates, and if non-vaccinated individuals remain compliant with physical distancing measures. Both require convincing, clear and appropriately targeted communication strategies by public health authorities. Significance Statement: SARS-CoV-2 vaccination campaigns are in progress in many countries around the world. As the vaccination coverage increases, the compliance with physical distancing measures aimed at reducing virus transmission may decline. Using a socio-epidemiological model we identify factors that are the drivers of increased transmission when SARS-CoV-2 prevalence is higher than the projected prevalence without vaccination. To maximize the benefits of vaccination campaigns, compliance in vaccinated and non-vaccinated groups should be targeted prioritizing one group over the other depending on the vaccination rate, the efficacy of vaccine in blocking the infection, and the circulating variant.
Open AccessThe importance of sustained compliance with physical distancing during COVID-19 vaccination rollout
Mass vaccination campaigns against SARS-CoV-2 are ongoing in many countries with increasing vaccination coverage enabling relaxation of lockdowns. Vaccination rollout is frequently supplemented with advisory from public health authorities for continuation of physical distancing measures. Compliance with these measures is waning while more transmissible virus variants such as Alpha (B.1.1.7) and Delta (B.1.617.2) have emerged. In this work, we considered a population where the waning of compliance depends on vaccine coverage. We used a SARS-CoV-2 transmission model which captures the feedback between compliance, infection incidence, and vaccination coverage to investigate factors that contribute to the increase of the prevalence of infection during the initial stages of the vaccination rollout as compared to no vaccination scenario. We analysed how the vaccine uptake rate affects cumulative numbers of new infections three and six months after the start of vaccination. Our results suggest that the combination of fast waning compliance in non-vaccinated population, low compliance in vaccinated population and more transmissible virus variants may result in a higher cumulative number of new infections than in a situation without vaccination. These adverse effects can be alleviated if vaccinated individuals do not revert to pre-pandemic contact rates, and if non-vaccinated individuals remain compliant with physical distancing measures. Both require convincing, clear and appropriately targeted communication strategies by public health authorities. Significance Statement: SARS-CoV-2 vaccination campaigns are in progress in many countries around the world. As the vaccination coverage increases, the compliance with physical distancing measures aimed at reducing virus transmission may decline. Using a socio-epidemiological model we identify factors that are the drivers of increased transmission when SARS-CoV-2 prevalence is higher than the projected prevalence without vaccination. To maximize the benefits of vaccination campaigns, compliance in vaccinated and non-vaccinated groups should be targeted prioritizing one group over the other depending on the vaccination rate, the efficacy of vaccine in blocking the infection, and the circulating variant.